Cervical cancer screening – a new viral paradigm : cervical cancer is the second most frequent cancer among women in South Africa and worldwide

Richter, Karin Louise

dc.contributor.author	Richter, Karin Louise
dc.date.accessioned	2011-08-03T06:27:29Z
dc.date.available	2011-08-03T06:27:29Z
dc.date.issued	2011-05
dc.description.abstract	There is now enough scientific evidence available to predict that conventional cervical cancer screening with cytology will eventually be replaced by testing for markers of HPV infection associated with disease progression. It is vital that clinicians understand the benefits, limitations and harms of testing. False-positives can be reduced by adhering to the guidelines for age-related testing and the recommended longer screening intervals. Patients must be well informed regarding the role of HPV infection testing in cervical cancer screening.	en_US
dc.description.uri	http://www.cmej.org.za/index.php/cmej	en_US
dc.identifier.citation	Richter, KL 2011, 'Cervical cancer screening – a new viral paradigm : cervical cancer is the second most frequent cancer among women in South Africa and worldwide', CME : Continuing Medical Education, vol. 29, no. 5, pp. 194, 196, 198-199.	en_US
dc.identifier.issn	1016-6742 (print)
dc.identifier.issn	2078-5143 (online)
dc.identifier.uri	http://hdl.handle.net/2263/16981
dc.language.iso	en	en_US
dc.publisher	Health and Medical Publishing Group	en_US
dc.rights	Health and Medical Publishing Group	en_US
dc.subject	Cervical cancer	en_US
dc.subject.lcsh	Cancer -- Diagnosis	en
dc.subject.lcsh	Papillomaviruses -- Testing	en
dc.subject.lcsh	Generative organs, Female -- Cancer -- Diagnosis -- South Africa	en
dc.title	Cervical cancer screening – a new viral paradigm : cervical cancer is the second most frequent cancer among women in South Africa and worldwide	en_US
dc.type	Article	en_US